Participated · Equity · May 2026

AlleSense, founded in 2020 as a La Trobe University spin‑out, has developed the NanoMslide—a nanofabricated microscope slide that generates vivid cellular contrast without chemical dyes. The label‑free imaging approach uses a special coating to create color contrast on tissue samples, aiming to simplify variable staining processes and integrate with digital pathology workflows. The company says the technology can improve detection of early‑stage cancers and increase diagnostic concordance among pathologists. AlleSense plans to use the new capital to advance clinical validation and commercialize the NanoMslide. Financially, the company has now raised A$5 million in the latest round on top of a A$2.5 million seed round in 2023. Support from Breakthrough Victoria and the AEA Innovate grant program is intended to accelerate commercialization and create skilled jobs as the company scales.

Participated · Series A · Sep 2025

Harvest B produces textured plant-based proteins and a blended meat range called B Strong that combine animal and plant proteins to increase protein per serving for institutional catering, aged care and foodservice wholesalers. Its product lineup imitates meats from diced chicken to pulled pork and beef mince, and is built on a patented multi-protein low‑moisture extrusion (LME) system for processing Australian plants. The company supplies business-to-business food settings across Australia and New Zealand and has partnerships with leading foodservice wholesalers. Harvest B plans to deepen collaboration with Victorian pulse producers and research institutions and to utilise Victoria’s faba bean processing industry to create an allergen‑free, sustainable protein range. The business emphasizes local supply chains, sustainable manufacturing and increasing food sovereignty while seeking to scale its advanced food processing capabilities. The recent financing is intended to accelerate manufacturing scale-up and expand market reach in institutional and manufacturing channels. Harvest B, founded in 2020, is developing what it describes as the world’s first meat ingredients system purpose-built for plant-based foods. The company combines food science and advanced manufacturing technologies to create naturally derived, sustainably produced plant-based meat ingredients that aim to deliver superior taste and health benefits. Harvest B’s product is intended to enable food manufacturers and brands to reduce the capital, expertise, and time required to make competitive plant-based meat products. The team hopes its specialised supply-chain approach will help bridge the quality gap with animal-based meat and accelerate industry scaling. Founders mentioned in the article are Kristi Riordan, Alfred Lo and Werner Fuggersberger. The company’s stated mission is to accelerate the world’s transition to a sustainable food system by addressing mid-stream ingredient and supply-chain challenges.

Participated · Series C · Jun 2025

Infleqtion builds a diversified portfolio of quantum technologies, including neutral-atom quantum computers, quantum optical clocks, RF receivers, inertial sensors, and the Superstaq quantum software platform. Its hardware and software are already in use by customers such as the U.S. Department of War, NASA, the U.K. government, and partners like NVIDIA. The company is expanding its government and commercial engagements, exemplified by multiple ARPA-E contracts aimed at tackling energy-related challenges. Under the new QC3 award, Infleqtion will employ its neutral-atom platform and a proprietary algorithm to search for novel high-temperature superconductors that could enable lossless power transmission. Parallel work under the ENCODE program applies quantum-enhanced methods to optimize the energy grid. Together, these projects position Infleqtion at the forefront of quantum applications in chemistry, materials science, and energy infrastructure. Although the article does not disclose revenue or user counts, the repeated selection for federal contracts highlights growing commercial traction and non-dilutive funding to support R&D.

Led · Seed · Feb 2025

Diag-Nose.io develops precision diagnostic and drug-discovery solutions for respiratory disease using its RhinoMAP™ platform. RhinoMAP™ combines machine learning (artificial intelligence) with advanced proteomics to enable precision-matched treatments based on patient-specific biological endotypes. The system uses the patented ABEL Microsampler™ to collect nasal liquid biopsy samples for comprehensive biomarker analysis. Insights from the platform are intended to identify disease progression, therapeutic responsiveness, and optimal treatment pathways. The company plans to use the seed funds to expand operations and R&D. Founded in 2020 and led by CEO Eldin Rostom, Diag-Nose.io is based in Seattle, WA.

Led · Series B · Nov 2024

Conflux Technology designs and manufactures high-performance heat exchangers using metal additive manufacturing, printing complex, single-part units that are lighter, smaller and more material- and energy-efficient. The company’s core product aims to overcome conventional heat-exchange limitations and help customers reach net-zero goals across sectors such as motorsports, high-powered industrial machines, hydrogen, e-mobility and defense. Conflux is developing Conflux Production Systems (CPS), an end-to-end automated manufacturing solution to replace traditional heat exchanger plants and scale production of complex AM structures. The company plans to use the new funding to accelerate CPS development, scale hiring, and expand customer support across the US, Europe and Asia. Conflux is partnering with Odys Aviation to develop a heat recuperator turbogenerator for integration into Odys’ Laila regional VTOL aircraft, targeting >40% fuel consumption reduction and enabling a 450-mile range with payloads up to 130 pounds. The company says it is addressing a $6 billion segment of the global heat exchanger market and intends to productize both designs and manufacturing processes so customers can produce Conflux heat exchangers locally. Conflux Technology designs and manufactures optimized metal heat exchangers using metal additive manufacturing combined with computational heat‑transfer simulation. Founded in 2017 by Michael Fuller, the company pairs FEA and CFD simulation with processing expertise and offers engineering services from initial design through post‑processing. Its customers span automotive, defense, aerospace and oil & gas, and it emphasizes complex monolithic geometries that improve performance, cost and lead time versus conventional devices. The firm has adopted ANSTO’s Synchrotron particle accelerator for sub‑macroscopic inspection and developed 'Conflux Quantify' software to analyze wall thickness, surface roughness and detect structural weaknesses earlier. With AUD 8.5 million raised in a Series A, Conflux says it will accelerate its transformation from R&D into full production, roll out long‑held plans, increase metal AM machine capacity and invest in series‑production platforms. Management also plans to grow the team and further vertically integrate final post‑processing to scale manufacturing.